Kerry Spear

Kerry Spear has a diverse and extensive work experience in the field of medicinal chemistry. Currently, they are serving as the Chief Science Officer and Co-Founder of Blue Oak Pharmaceuticals since September 2016. Prior to this, Kerry worked as an Adjunct Professor of Medicinal Chemistry at Fudan University starting from June 2013.

Before joining Blue Oak Pharmaceuticals and Fudan University, Kerry held various managerial positions at different pharmaceutical companies. Kerry served as the Vice President of Medicinal Chemistry at Sunovion Pharmaceuticals Inc. from July 2005 to July 2016, and as the Executive Director from July 2005 to March 2008. From April 2008 to October 2010, Kerry was the Vice President of Medicinal Chemistry at Sepracor.

Kerry has also held leadership positions at other notable pharmaceutical companies. Kerry served as the Vice President at Daiichi Asubio Medical Research Labs (DAIAMED) in 2004, Infinity Pharmaceutical from 2003 to 2004, Icagen from 2000 to 2003, and as the Director of Medicinal Chemistry at Icagen from 1997 to 2000. Additionally, Kerry worked as the Associate Director of Medicinal Chemistry at Chiron Corporation from 1993 to 1997.

Kerry's early career includes roles as a Sr. Scientist at Arris Pharmaceuticals from 1991 to 1993 and at Triton Biosciences from 1989 to 1991.

Overall, Kerry Spear's work experience showcases their expertise in medicinal chemistry and their ability to hold leadership positions in the pharmaceutical industry.

Kerry Spear completed a Bachelor of Science degree in Chemistry at Juniata College from 1970 to 1974. They then pursued further education, earning a Ph.D. in Organic Chemistry at the University of Wisconsin-Madison from 1974 to 1979. Following that, they completed a Post Doctorate in Organic Chemistry at the University of California, Berkeley from 1979 to 1981.